Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Papalia

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Biochemistry|March 17, 2015
Functional label-free assays for characterizing the in vitro mechanism of action of small molecule modulators of capsid assemblyLatesh Lad, Sheila Clancy, David Koditek, et al.
Journal of Molecular Biology|February 13, 2019
The KN-93 Molecule Inhibits Calcium/Calmodulin-Dependent Protein Kinase II (CaMKII) Activity by Binding to Ca<sup>2+</sup>/CaMMelanie H Wong, Alexandra B Samal, Mike Lee, et al.
Cell Reports|July 27, 2025
Identification and engineering of potent bispecific antibodies that protect against herpes simplex virus recurrent diseaseChingwei V Lee, Hector Viadiu, Apurva Kalamkar, et al.
Analytical Biochemistry|March 17, 2007
Thermodynamic benchmark study using Biacore technologyIva Navratilova, Giuseppe A Papalia, Rebecca L Rich, et al.
Analytical Biochemistry|September 30, 2006
Comparative analysis of 10 small molecules binding to carbonic anhydrase II by different investigators using Biacore technologyGiuseppe A Papalia, Stephanie Leavitt, Maggie A Bynum, et al.
The Journal of Clinical Investigation|July 20, 2018
ASK1 contributes to fibrosis and dysfunction in models of kidney diseaseJohn T Liles, Britton K Corkey, Gregory T Notte, et al.
Nature Medicine|September 11, 2019
A highly potent long-acting small-molecule HIV-1 capsid inhibitor with efficacy in a humanized mouse modelStephen R Yant, Andrew Mulato, Derek Hansen, et al.
Analytical Biochemistry|June 9, 2004
Comparative analyses of a small molecule/enzyme interaction by multiple users of Biacore technologyMichelle J Cannon, Giuseppe A Papalia, Iva Navratilova, et al.
Journal of Medicinal Chemistry|October 1, 2025
Discovery of Lenacapavir: First-in-Class Twice-Yearly Capsid Inhibitor for HIV-1 Treatment and Pre-exposure ProphylaxisEda Canales, Winston Tse, Scott D Schroeder, et al.
Nature|July 3, 2020
Clinical targeting of HIV capsid protein with a long-acting small moleculeJohn O Link, Martin S Rhee, Winston C Tse, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Biochemistry|March 17, 2015
Functional label-free assays for characterizing the in vitro mechanism of action of small molecule modulators of capsid assemblyLatesh Lad, Sheila Clancy, David Koditek, et al.
Journal of Molecular Biology|February 13, 2019
The KN-93 Molecule Inhibits Calcium/Calmodulin-Dependent Protein Kinase II (CaMKII) Activity by Binding to Ca<sup>2+</sup>/CaMMelanie H Wong, Alexandra B Samal, Mike Lee, et al.
Cell Reports|July 27, 2025
Identification and engineering of potent bispecific antibodies that protect against herpes simplex virus recurrent diseaseChingwei V Lee, Hector Viadiu, Apurva Kalamkar, et al.
Analytical Biochemistry|March 17, 2007
Thermodynamic benchmark study using Biacore technologyIva Navratilova, Giuseppe A Papalia, Rebecca L Rich, et al.
Analytical Biochemistry|September 30, 2006
Comparative analysis of 10 small molecules binding to carbonic anhydrase II by different investigators using Biacore technologyGiuseppe A Papalia, Stephanie Leavitt, Maggie A Bynum, et al.
The Journal of Clinical Investigation|July 20, 2018
ASK1 contributes to fibrosis and dysfunction in models of kidney diseaseJohn T Liles, Britton K Corkey, Gregory T Notte, et al.
Nature Medicine|September 11, 2019
A highly potent long-acting small-molecule HIV-1 capsid inhibitor with efficacy in a humanized mouse modelStephen R Yant, Andrew Mulato, Derek Hansen, et al.
Analytical Biochemistry|June 9, 2004
Comparative analyses of a small molecule/enzyme interaction by multiple users of Biacore technologyMichelle J Cannon, Giuseppe A Papalia, Iva Navratilova, et al.
Journal of Medicinal Chemistry|October 1, 2025
Discovery of Lenacapavir: First-in-Class Twice-Yearly Capsid Inhibitor for HIV-1 Treatment and Pre-exposure ProphylaxisEda Canales, Winston Tse, Scott D Schroeder, et al.
Nature|July 3, 2020
Clinical targeting of HIV capsid protein with a long-acting small moleculeJohn O Link, Martin S Rhee, Winston C Tse, et al.
Pageof 4